Tocqueville Asset Management L.P. bought a new stake in Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Free Report) during the second quarter, HoldingsChannel.com reports. The firm bought 55,500 shares of the company’s stock, valued at approximately $315,000.
Several other institutional investors have also recently bought and sold shares of SENS. Great Lakes Advisors LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth about $2,362,000. BlackRock Inc. bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at approximately $15,867,000. Deutsche Bank AG bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter valued at approximately $223,000. J.Safra Asset Management Corp bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $636,000. Finally, State of Wyoming bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $67,000. Institutional investors and hedge funds own 12.36% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on SENS. HC Wainwright lowered their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a report on Tuesday, May 12th. Stifel Nicolaus cut their price objective on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings cut Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, August 12th. Finally, Mizuho dropped their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $17.20.
Senseonics Holdings, Inc. Common Stock Price Performance
SENS opened at $9.71 on Friday. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. Senseonics Holdings, Inc. Common Stock has a fifty-two week low of $4.79 and a fifty-two week high of $11.58. The stock’s 50 day simple moving average is $6.11. The company has a market cap of $405.88 million, a price-to-earnings ratio of -4.35 and a beta of 1.01.
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). The business had revenue of $14.48 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, equities research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current year.
Insiders Place Their Bets
In related news, Director Douglas A. Roeder acquired 13,953 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the acquisition, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 4.70% of the stock is owned by insiders.
Senseonics Holdings, Inc. Common Stock Profile
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Featured Stories
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding SENS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Free Report).
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
